Pharmacotherapy of generalized anxiety disorder: State of the art;Pharmacothérapie de l'anxiété géné ralisée: Etat actuel

Praxis

Volumn 92, Issue 42, 2003, Pages 1775-1779

  Zullino, D F ^a   Hattenschwiler J ^b   Mattia, M ^c   Stankovic, M ^a   Khazaal, Y ^a   Borgeat, F ^a  

^a DEPT UNIV DE PSYCHIATRIE ADULTE   (Switzerland)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^c Clinica Casa Alabardia   (Switzerland)

Author keywords

Antidepressants; Benzodiazepines; Generalized anxiety disorder; Guidelines; Pharmacotherapy

Indexed keywords

EID: 80051666194     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.92.42.1775     Document Type: Review

References (25)

1. Lydiard R B An overview of generalized anxiety disorder: disease state - appropriate therapy. Clinical Therapeutics 2000: 22: A3-A24. (Pubitemid 30263282)
2. Kessler, R C and Wittchen, H U Patterns and correlates of generalized anxiety disorder in community samples. Journal of Clinical Psychiatry 63[suppl 8], 4-10. 2002. (Pubitemid 34535251)
3. Narrow w e, Rae D S, Robins L N, Regier D A. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 2002: 59: 115-123.
4. Wittchen, H U, Kessler, R C, Beesdo, K., Krause, P., Höfler, M, and Hoyer, J. Generalized anxiety and depression in primary care: prevalence, recognition, and management. Journal of Clinical Psychiatry 63[suppl 8], 24-34. 2002. (Pubitemid 34535254)
5. Brown C., Schulberg H C, Madonia M J, Shear M K, Houck P R Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996: 153: 1293-1300. (Pubitemid 26334202)
6. Rickels K., Downing R., Schweizer E., Hassman H. Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry 1993: 50: 884-895. (Pubitemid 23330980)
7. McLeod D R, Hoehn-Saric R., Porges S W, Kowalski P A, Clark C M Therapeutic effects of imipramine are counteracted by its metabolite, desipramine, in patients with generalized anxiety disorder. J Clin Psychopharmacol 2000: 20: 615-621.
8. Moller H J, Volz H P, Reimann I W, Stoll K D Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam- treated group. J Clin Psychopharmacol 2001: 21: 59-65. (Pubitemid 32096751)
9. Wingerson D., Nguyen C., Roy-Byrne P P Clomipramine treatment for generalized anxiety disorder. J Clin Psychopharmacol 1992: 12: 214-215.
10. Rausch J L, Mac Hobby H., Shendarkar N., Johnson M E, Li J. Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis. J Clin Psychopharmacol 2001: 21: 139-142. (Pubitemid 32221050)
11. Wylie M E, Miller M D, Shear M K et al. Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data. J Geriatr Psychiatry Neurol 2000: 13: 43-48. (Pubitemid 30224008)
12. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 2001: 344: 1279-1285.
13. Fairbanks J M, Pine D S, Tancer N K et al. Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. J Child Adolesc Psychopharmacol 1997: 7: 17-29. (Pubitemid 27252847)
14. Silverstone P H, Salinas E. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder. J Clin Psychiatry 2001: 62: 523-529. (Pubitemid 32703091)
15. Rynn M A, Siqueland L., Rickels K. Placebo-Controlled Trial of Sertraline in the Treatment of Children With Generalized Anxiety Disorder. Am J Psychiatry 2001: 158: 2008-2014. (Pubitemid 33104106)
16. Rocca P., Fonzo V., Scotta M., Zanalda E., Ravizza L. Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 1997: 95: 444-450. (Pubitemid 27244846)
17. Pollack M H, Zaninelli R, Goddard A et al Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry 2001: 62: 350-357. (Pubitemid 32545557)
18. Hedges D W, Reimherr F W, Strong R E, Halls C H, Rust C. An open trial of nefazodone in adult patients with generalized anxiety disorder. Psychopharmacol Bull 1996: 32: 671-676. (Pubitemid 26428272)
19. DeMartinis N A, Schweizer E., Rickels K. An open-label trial of nefazodone in high comorbidity panic disorder. J Clin Psychiatry 1996: 57: 245-248. (Pubitemid 26230647)
20. Goodnick P J, Puig A., Devane C L, Freund B V Mirtazapine in major depression with comorbid generalized anxiety disorder. J Clin Psychiatry 1999: 60: 446-448. (Pubitemid 29369799)
21. Perugi G., Toni C., Ruffolo G., Frare F., Akiskal H. Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series. Pharmacopsychiat 2001: 34: 137-141. (Pubitemid 32701763)
22. Davidson J R T, DuPont R L, Hedges D., Haskins J T Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. J Clin Psychiatry 1999: 60: 528-535. (Pubitemid 29413473)
23. Rickels K., Pollack M H, Sheehan D V, Haskins J T Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. Am J Psychiatry 2000: 157: 968-974. (Pubitemid 30412349)
24. Allgulander C., Hackett D., Salinas E. Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study. Br J Psychiatry 2001: 179: 15-22.
25. Gelenberg A J, Lydiard R B, Rudolph R L, Aguiar L., Haskins J T, Salinas E. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder. JAMA 2000: 283: 3082-3088. (Pubitemid 30399718)